As of January 22, 2025, Ovid Therapeutics (OVID) has a market cap of $49.920 million USD. According to our data, Ovid Therapeutics is ranked No.8158 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $49.92 M |
-24.73%
|
Dec 31, 2024 | $66.32 M |
-70.99%
|
Dec 29, 2023 | $0.23 B |
73.12%
|
Dec 30, 2022 | $0.13 B |
-42.06%
|
Dec 31, 2021 | $0.23 B |
38.96%
|
Dec 31, 2020 | $0.16 B |
-44.34%
|
Dec 31, 2019 | $0.29 B |
71.49%
|
Dec 31, 2018 | $0.17 B |
-75.48%
|
Dec 29, 2017 | $0.70 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Sage Therapeutics
SAGE
|
$0.43 B |
-0.000 M
|
USA
|
Marinus Pharmaceuticals
MRNS
|
$30.09 M |
0.000 M
|
USA
|
Ultragenyx
RARE
|
$3.97 B |
0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
PTC Therapeutics
PTCT
|
$3.48 B |
-0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Agenus
AGEN
|
$86.42 M |
0.000 M
|
USA
|
Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
Amicus Therapeutics
FOLD
|
$2.85 B |
0.000 M
|
USA
|
Neurocrine Biosciences
NBIX
|
$14.86 B |
-0.000 M
|
USA
|
Jazz Pharmaceuticals
JAZZ
|
$7.31 B |
0.000 M
|
Ireland
|
Market Cap | = | OVID Stock Price | * | OVID Shares Outstanding |
= | $0.70 | * | 71.01 M | |
= | $49.92 M |